University of Washington
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Washington sits in the top decile of US sponsors by registered trial count (#30 of 15,742 sponsors by registered trial count).
University of Washington: 1,048 sponsored US clinical trials, 156 recruiting.
University of Washington sponsors 1,048 registered US clinical trials on ClinicalTrials.gov, 156 of them currently recruiting, and 720 completed. 104 of these trials are in Phase 3-4 (later-stage) and 320 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Depression, with 13 trials.
Top-decile sponsor footprint
University of Washington ranks in the top decile of sponsors by registered trial count (#30 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
720 of 816 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (88.2%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,048 total, page 15 of 21
Endotracheal Tubes for Prevention of Ventilator-associated Pneumonia
NCT01744483
Vaccine Therapy in Treating Patients With Stage IV Hormone Receptor Positive Breast Cancer
NCT01729884
Reducing Disabilities in Alzheimer's Disease (RDAD) Translation in Area Agencies on Aging (AAAs)
NCT01708304
Vorinostat in Treating Patients With Stage IV Breast Cancer Receiving Hormone Therapy
NCT01720602
18F-FLT PET/CT in Measuring Cell Proliferation in Patients With Brain Tumors
NCT02167204
Fecal Microbiota Transplantation for Ulcerative Colitis
NCT01742754
Memory and Thinking Skills Workshop to Improve Cognition in Gynecologic and Breast Cancer Survivors With Cognitive Symptoms
NCT01641068
Cognitive Behavioral Therapy for COPD
NCT01694628
Effects of IV Administration of Ketamine on the Analgesia Nociception Index (ANI) Measured With the PhysioDoloris
NCT01717521
FLuctuATion Reduction With inSULin and Glp-1 Added togetheR (FLAT-SUGAR)
NCT01524705
IV Acetaminophen as an Adjunct Analgesic in Cardiac Surgery
NCT01544062
Trauma Survivors Outcomes and Support Study IV
NCT01625416
Mandibular Overdenture Clinical Trial Comparing Parallel Sided and Tapered Dental Implants
NCT03272828
Eribulin Mesylate in Treating Patients With Recurrent or Metastatic Salivary Gland Cancer
NCT01613768
Antibiotic Prophylaxis Before Percutaneous Gastrostomy
NCT01424085
Amiodarone, Lidocaine or Neither for Out-Of-Hospital Cardiac Arrest Due to Ventricular Fibrillation or Tachycardia
NCT01401647
Combined Behavioral and Analgesic Trial for Fibromyalgia
NCT01598753
Pazopanib Hydrochloride Followed by Chemotherapy and Surgery in Treating Patients With Soft Tissue Sarcoma
NCT01446809
Pain and Symptom Management in Rural Communities
NCT02070874
Vaccine Therapy in Treating Patients With Stage III-IV or Recurrent Ovarian Cancer
NCT01322802
Contingency Management of Alcohol Abuse in the Severely Mentally ILL
NCT01567943
Home-Based or Clinic-Based Human Papillomavirus (HPV) Screening
NCT01550783
Pomegranate and Hemodialysis Pilot Trial
NCT01562340
Field Trial of Hypotensive Versus Standard Resuscitation for Hemorrhagic Shock After Trauma
NCT01411852
Effect of Tenofovir on Genital Herpes Simplex Virus (HSV) Shedding
NCT01448616
Two Interventions for Early Stage Dementia: A Comparative Efficacy Trial
NCT01550718
Washington Study of Hemofiltration After Out-of-Hospital Cardiac Arrest
NCT01509040
Collaborative Adolescent Research on Emotions and Suicide
NCT01528020
Iodine I 131 and Pazopanib Hydrochloride in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer Previously Treated With Iodine I 131 That Cannot Be Removed By Surgery
NCT01413113
Fallopian Tube Removal as a Method of Ovarian Cancer Prevention: A Descriptive Study
NCT01544049
Fluoride Administered and Retained After Topical Fluoride Varnish
NCT01754831
CoQ10 Biomarker Trial
NCT01408680
FDG PET and DCE-MRI in Predicting Response to Treatment in Patients With Breast Cancer
NCT01931709
Hospice Problem Solving Intervention
NCT01444027
Levels of Raltegravir in the Female Genital Tissue
NCT01327482
PROS-2 Dose Response Effects of Exogenous Testosterone on the Prostate
NCT01327495
Radiation Therapy, Cisplatin, and Etoposide in Treating Patients With Non-small Cell Lung Cancer That Cannot Be Removed by Surgery
NCT01411098
FLT PET in Measuring Treatment Response in Patients With Newly Diagnosed Estrogen Receptor-Positive, HER2-Negative Stage I-III Breast Cancer
NCT01928186
Managing Childhood Abdominal Pain
NCT01620606
Diagnostic Accuracy of Cardiac CT Perfusion Compared to PET Imaging
NCT01434043
Comparative Effectiveness Research Study of Peripheral Arterial Disease (PAD)
NCT01378260
Vaccine Therapy in Combination With Rintatolimod and/or Sargramostim in Treating Patients With Stage II-IV HER2-Positive Breast Cancer
NCT01355393
Use of Passive, Adaptive, and Active Prosthetic Knees in Persons With Unilateral, Transfemoral Amputation
NCT02219230
Continuous Chest Compressions vs AHA Standard CPR of 30:2
NCT01372748
Pain Quality Study
NCT01321190
TLR8 Agonist VTX-2337 and Cetuximab in Treating Patients With Locally Advanced, Recurrent, or Metastatic Squamous Cell Cancer of Head and Neck
NCT01334177
Improving Care Provided to Patients Treated in a Level 1 Trauma Center Post-suicide Attempt
NCT01355848
Calorie Reduction Or Surgery: Seeking Remission for Obesity And Diabetes
NCT01295229
Lumbar Epidural Steroid Injections for Spinal Stenosis Multicenter Randomized, Controlled Trial (LESS Trial)
NCT01238536
Liposomal Cytarabine and High-Dose Methotrexate in Treating Patients With Central Nervous System Metastases From Breast Cancer
NCT00992602
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 127 |
| Phase 2 | 193 |
| Phase 3 | 39 |
| Phase 4 | 65 |
What is open in the University of Washington pipeline
156 recruiting of 1,048 indexed (15% open); 720 completed (69%).
Phase mix: 104 late (III/IV) vs 320 early (I/II) (early-phase heavy).
Top condition: Depression (13 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Washington: open-pipeline peers nationwide
Peers matched on 1,048 registered trials and 15% open enrollment, not the therapeutic-area sidebar.
University of Washington sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,048 trials (± recruiting share)
- University of Wisconsin, Madison · 1,039 trials · 15% recruiting
- Bristol-Myers Squibb · 1,025 trials · 7% recruiting
- University of Florida · 1,106 trials · 15% recruiting
- University of North Carolina, Chapel Hill · 1,109 trials · 10% recruiting
Sponsors near 15% open enrollment (± trial volume)
- Dompé Farmaceutici S.p.A · 15% recruiting · 27 trials
- Vanderbilt-Ingram Cancer Center · 15% recruiting · 189 trials
- Arizona State University · 15% recruiting · 187 trials
- Georgetown University · 15% recruiting · 227 trials
Related
What to do with this University of Washington page
1,048 registered trials is a research-attention snapshot, not an endorsement of University of Washington or any single study.
- 156 of University of Washington's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Depression is the condition University of Washington studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Depression trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of Washington pipeline card: 1,048 registered trials from official public datasets.Report a data error.